Table 4 Area under the curve (AUC) and number of participants included (N) for each assessment level in the prediction of mild cognitive impairment with CSF amyloid positivity (MCI + A+).

From: Stepwise approach to alzheimer’s disease diagnosis in primary care using cognitive screening, risk factors, neuroimaging and plasma biomarkers

Assessment Level

AUC

N

Interview level (Level 1)

0.779

239

Interview + MRI (Level 2)

0.868

239

Interview + MRI + Biomarkers (Level 3)

0.938

163